IL-33 promotes hepatic and pulmonary fibrosis by suppressing MMP-9 expression and enhancing TIMP1 expression, thereby creating an imbalance between MMPs and TIMP1 (Zhang et al., 2021; Li, 2011). The gene discussed is TIMP1; the disease is pulmonary fibrosis.